BIODESIX INC — Director's Dealing 2021

Dec 8, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2021-12-06

Reporting Person: Kayyem Jon Faiz (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-06	Restricted Stock Units	$	A	31619	Acquired		Common Stock (31619)	Direct
2021-12-06	Stock Options (Right to Buy)	$5.93	A	50368	Acquired	2031-12-05	Common Stock (50368)	Direct
2021-12-07	Stock Options (Right to Buy)	$5.67	A	27038	Acquired	2031-12-06	Common Stock (27038)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F2: These restricted stock units will vest in full on December 6, 2022, generally subject to the reporting person's continued service on the Issuer's board of directors (the "Board") through the applicable vesting date, and have no expiration date.

F3: This option vests 40% on December 6, 2023, and the remaining 60% in 36 successive, equal monthly installments measured from December 6, 2023, generally subject to the reporting person's continued service on the Board through the applicable vesting date.

F4: This option will vest in full on March 31, 2022, subject to the reporting person's continued service on the Board through the applicable vesting date. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period.